Highlights Rebus Holdings, Inc.

Equities

RBSH

US75619J1034

Market Closed - OTC Markets Other stock markets 10:59:36 2024-06-13 EDT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		0.00%	-98.04%

2023	Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
2023	Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Inspyr Therapeutics Announces New Holding Company Structure	21-10-12	CI
Reverse Split: 1 of 75	21-10-11	FA
Inspyr Therapeutics : AGREEMENT AND PLAN OF MERGER (Form 8-K)	21-10-05	PU
Inspyr Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Inspyr Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Inspyr Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
Inspyr Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-20	CI
Inspyr Therapeutics, Inc. Enters into Termination of License Agreement with Ridgeway Therapeutics, Inc	20-10-08	CI
Inspyr Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Inspyr Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-07-06	CI
Reverse Split: 1 of 30	20-06-29	FA
Inspyr Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-05-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rebus Holdings, Inc.

Equities

RBSH

US75619J1034

Highlights

Filters